Target intelligence / Profile preview

Cell-surface receptors and glycans used by the viral vector for cell entry

Molecular classification
Receptor, Other
01

Overview

Cell-surface receptors and glycans used by viral vectors for cell entry represent a diverse group of host molecules that facilitate the initial attachment and subsequent internalization of viral particles into a host cell (Marsh & Helenius, 2006, Cell). These molecules include high-affinity protein receptors, such as the Coxsackievirus and adenovirus receptor (CAR), and low-affinity attachment factors like heparan sulfate proteoglycans (HSPGs) (Maginnis, 2018, J. Mol. Biol.). The specific interaction between a viral capsid or envelope protein and these host factors determines the vector's tissue tropism and delivery efficiency (Pillay & Carette, 2017, Curr. Opin. Virol.). In gene therapy, vectors are often engineered or pseudotyped to utilize specific receptors to ensure targeted delivery to desired cell types. While these receptors are essential for viral entry, they also serve critical endogenous functions, such as cell signaling, adhesion, and transport, which can be disrupted by therapeutic interventions (Baranowski et al., 2001, Science). Consequently, drugs targeting these entry pathways, such as entry inhibitors like Maraviroc or Bulevirtide, must be designed to minimize interference with the host's normal physiological processes (Dorr et al., 2005, Antimicrob. Agents Chemother.).

Other names
Viral entry receptorsHost cell attachment factorsViral attachment sitesVirus-receptor interactionsHost determinants of viral entry
02

Mechanism of action

Inhibition of viral entry by competitively binding to host cell surface receptors or attachment factors, thereby preventing viral docking, conformational changes, and membrane fusion.

03

Biological functions

Cell entryViral attachmentCell-cell adhesionSignal transductionEndocytosis
04

Disease associations

Infection
05

Safety considerations

Disruption of normal physiological signalingPotential for systemic toxicity if the receptor is widely expressedRisk of viral resistance through alternative receptor usageImmunological reactions to the therapeutic agent
06

Interacting drugs

Maraviroc

4 more in the full profile.

07

Biomarkers

Host receptor expression levelsCell surface glycan profilingGenetic polymorphisms in receptor genes (e.g., CCR5-delta32)

Beyond the preview

Go deeper on Cell-surface receptors and glycans used by the viral vector for cell entry.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-surface receptors and glycans used by the viral vector for cell entry.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call